Dr. Scott Gottlieb
At The Constellation Forum 2025 in New York, Gottlieb said there are and will continue to be challenges regulating software when it comes to AI devices.
Also: Jonathan Bush, Dr. Scott Gottlieb embrace the board of directors.
According to the Washington Post, which broke the news, the commissioner is leaving to spend more time with his family.
Released yesterday, the document outlines FDA's preference toward single applications for combination products.
The new guidance aims to modernize the process and generate more market competition.